Bioxyne Limited (BXN) is an Australian life science, health and medical technology company involved in the development, manufacture and distribution of nutritional supplements and beauty products through wholesale and direct sales channels. The group has a global distribution agreement with Denmark’s Chr Hansen to manufacture, market, supply and distribute its proprietary probiotic strain of Lactobacillus Fermentum PCC for over the counter dietary supplement products.
Bioxyne Limited operators in Consumer Staple sector and under industry of Personal Products. The company website is: http://www.bioxyne.com.
You can also check out dividend history for similar stocks in the same sector as follows:
BXN Dividend Dates
Please click the table header to sort the data.
No Dividend Dates Found